Joseph Garrity | Head of Autologous Cell Therapy Associate Director, Commercial Development
Lonza

Joseph Garrity, Head of Autologous Cell Therapy Associate Director, Commercial Development, Lonza

Joe Garrity is the Head of Autologous Cell Therapy, Commercial Development at Lonza Cell and Gene Technologies where he works within their global Cell and Gene business unit. He works within the business leadership team to enable strategic development and growth of the autologous modality in Lonza CGT, as well as works with operations, development, and quality teams to streamline the clinical and commercial manufacturing services and offers provided by Lonza. Joe has an educational background in biochemistry and a professional background of nearly a decade within the cell and gene CDMO space that has covered positions within development, operations, and business functions.

Appearances:



Day 3: Friday 21st May 2021 - Commercialisation, Pricing & Access @ 15:30

Panel: Technology Evolution and Supply Chain

last published: 10/May/21 08:45 GMT

back to speakers